Balyasny Asset Management’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,004
Closed -$4.8K 2444
2023
Q3
$4.8K Sell
1,004
-2,350
-70% -$12.9K ﹤0.01% 2190
2023
Q2
$20.1K Sell
3,354
-2,984
-47% -$23.9K ﹤0.01% 2157
2023
Q1
$47.3K Sell
6,338
-1,750
-22% -$17.5K ﹤0.01% 2395
2022
Q4
$100K Buy
8,088
+6,929
+598% +$122K ﹤0.01% 2252
2022
Q3
$24K Sell
1,159
-513
-31% -$14.3K ﹤0.01% 2560
2022
Q2
$46K Buy
+1,672
New +$57.2K ﹤0.01% 2380

Other funds holding AFMD

Balyasny Asset Management's AFMD Position: Q4 2023 in Review

Balyasny Asset Management sold out of Affimed (AFMD) in Q4 2023, closing a stake of 1,004 shares — an estimated $4.8K sold.

Balyasny Asset Management first reported a position in AFMD in Q2 2022 and held it in 6 quarters. The position peaked at $100K in Q4 2022. 67 funds tracked by Wall St. Rank hold AFMD as of Q4 2023.

  • Balyasny Asset Management reported no remaining Affimed position as of Q4 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 1,004 Affimed shares in Q4 2023, an estimated $4.8K.
  • Balyasny Asset Management first reported a position in Affimed in Q2 2022 and held it in 6 quarters.
  • Balyasny Asset Management's Affimed position peaked at $100K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held Affimed as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.